T-antigen regulated expression reduces apoptosis of Tag-transformed human myoblasts

被引:4
作者
Corti, S
Salani, S
Del Bo, R
Torrente, Y
Strazzer, S
Belicchi, M
Paganoni, S
Li, Z
Comi, GP
Bresolin, N
Paulin, D
Scarlato, G
机构
[1] Univ Milan, IRCCS Osped Maggiore Policlin, Inst Clin Neurol, I-20122 Milan, Italy
[2] IRCCS Eugenio Medea, Bosisio Parini, Italy
[3] Univ Milan, Inst Clin Neurol, Ctr Dino Ferrari, I-20122 Milan, Italy
[4] Univ Paris 07, F-75005 Paris, France
关键词
myogenic cells; SV40 large T antigen; apoptosis; vimentin; myotube;
D O I
10.1007/PL00000773
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The generation of human myogenic cell lines could potentially provide a valuable source for cell transplantation in myopathies. The dysregulation of proliferative-differentiative signals by viral oncogenes can result in the induction of apoptosis. Whether apoptosis occurred in myogenic cells expressing large T antigen (Tag) from SV40 upon differentiation was unknown. Human muscle satellite cells were transfected with two different constructs, containing either an origin-defective SV40 genome or Tag under vimentin promoter control. When differentiation was triggered, Tag expression reduced the formation was of myotubes and dead cells showing apoptotic features were present. However, the cells expressing SV40 Tag under vimentin promoter control retained their capacity to form myotubes and expressed the myofibrillar proteins as myosin heavy chain and dystrophin when Tag expression was silent. Their apoptotic rate was similar to that of untransfected cells. The observation that apoptosis can be prevented by the down-regulation of Tag suggests that the programmed cell death induced in transformed cells can be reversed, and confirms the regulatory efficiency of the human vimentin promoter.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 25 条
  • [1] [Anonymous], 1989, SYNTHETIC OLIGONUCLE
  • [2] Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene
    Berghella, L
    De Angelis, L
    Coletta, M
    Berarducci, B
    Sonnino, C
    Salvatori, G
    Anthonissen, C
    Cooper, R
    Butler-Browne, GS
    Mouly, V
    Ferrari, G
    Mavilio, F
    Cossu, G
    [J]. HUMAN GENE THERAPY, 1999, 10 (10) : 1607 - 1617
  • [3] SV40 SMALL T-ANTIGEN ENHANCES THE TRANSFORMATION ACTIVITY OF LIMITING CONCENTRATIONS OF SV40 LARGE T-ANTIGEN
    BIKEL, I
    MONTANO, X
    AGHA, ME
    BROWN, M
    MCCORMACK, M
    BOLTAX, J
    LIVINGSTON, DM
    [J]. CELL, 1987, 48 (02) : 321 - 330
  • [4] DEFECTIVE MYOBLASTS IDENTIFIED IN DUCHENNE MUSCULAR-DYSTROPHY
    BLAU, HM
    WEBSTER, C
    PAVLATH, GK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (15): : 4856 - 4860
  • [5] SV40-INDUCED IMMORTALIZATION OF HUMAN-CELLS
    BRYAN, TM
    REDDEL, RR
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (04): : 331 - 357
  • [6] Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy
    Decary, S
    Mouly, V
    BenHamida, C
    Sautet, A
    Barbet, JP
    ButlerBrowne, GS
    [J]. HUMAN GENE THERAPY, 1997, 8 (12) : 1429 - 1438
  • [7] Deschenes I, 1997, MUSCLE NERVE, V20, P437, DOI 10.1002/(SICI)1097-4598(199704)20:4<437::AID-MUS6>3.3.CO
  • [8] 2-2
  • [9] The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts
    Fimia, GM
    Gottifredi, V
    Bellei, B
    Ricciardi, MR
    Tafuri, A
    Amati, P
    Maione, R
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (06) : 1449 - 1463
  • [10] Gottifredi V, 1999, J CELL SCI, V112, P2397